These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29032922)

  • 1. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [
    Majuri J; Joutsa J; Johansson J; Voon V; Parkkola R; Alho H; Arponen E; Kaasinen V
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1281-1288. PubMed ID: 29032922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
    Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V
    Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
    Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
    Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study.
    Bellmunt-Gil A; Majuri J; Arponen E; Kaasinen V; Joutsa J
    J Behav Addict; 2023 Oct; 12(3):670-681. PubMed ID: 37561637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study.
    Majuri J; Joutsa J; Arponen E; Forsback S; Kaasinen V
    Neuroimage; 2018 Dec; 183():1-6. PubMed ID: 30077742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging study.
    Skandali N; Majuri J; Joutsa J; Baek K; Arponen E; Forsback S; Kaasinen V; Voon V
    Psychol Med; 2022 Oct; 52(14):3280-3288. PubMed ID: 33568248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
    Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
    Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in brain serotonin transporter availability in panic disorder.
    Maron E; Tõru I; Hirvonen J; Tuominen L; Lumme V; Vasar V; Shlik J; Nutt DJ; Helin S; Någren K; Tiihonen J; Hietala J
    J Psychopharmacol; 2011 Jul; 25(7):952-9. PubMed ID: 21148024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
    Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
    Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
    Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
    Jarkas N; Voll RJ; Williams L; Goodman MM
    Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
    Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.